PMV Pharmaceuticals, Inc. SEC filings PMVP
PMV Pharmaceuticals, Inc. has 390 filings in SEC EDGAR's recent list, going back to Mar 2, 2017. Its latest annual report, Form ARS, was filed on Apr 22, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 5, 2026 (officer or director change, regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Oct 5, 2026 | Oct 1, 2026 |
| 8-K |
Current report
Material agreement, Other events
|
Sep 2, 2026 | Aug 31, 2026 |
| 424B5 | Prospectus supplement | Sep 2, 2026 | — |
| 424B3 | Prospectus | Aug 31, 2026 | — |
| 424B5 | Prospectus supplement | Aug 31, 2026 | — |
| 8-K |
Current report
Other events
|
Aug 31, 2026 | Aug 31, 2026 |
| 10-Q | Quarterly report | Aug 14, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 14, 2026 | Aug 14, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jun 5, 2026 | Jun 4, 2026 |
| 10-Q | Quarterly report | May 12, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations
|
May 12, 2026 | May 12, 2026 |
| ARS | Annual report to shareholders | Apr 22, 2026 | Dec 31, 2025 |
| DEFA14A | Additional proxy material | Apr 22, 2026 | — |
| DEF 14A | Proxy statement | Apr 22, 2026 | Jun 4, 2026 |
| S-8 | Employee stock plan registration | Mar 6, 2026 | — |
| 8-K |
Current report
Results of operations
|
Mar 6, 2026 | Mar 6, 2026 |
| 10-K | Annual report | Mar 6, 2026 | Dec 31, 2025 |
| 10-Q | Quarterly report | Nov 12, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 12, 2025 | Nov 12, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Sep 10, 2025 | Sep 10, 2025 |
| 10-Q | Quarterly report | Aug 7, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 7, 2025 | Aug 7, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Jun 9, 2025 | Jun 5, 2025 |
| 10-Q | Quarterly report | May 9, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations
|
May 9, 2025 | May 9, 2025 |
| ARS | Annual report to shareholders | Apr 25, 2025 | Dec 31, 2024 |
| DEFA14A | Additional proxy material | Apr 25, 2025 | — |
| DEF 14A | Proxy statement | Apr 25, 2025 | Jun 5, 2025 |
| 10-K | Annual report | Mar 3, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Results of operations
|
Mar 3, 2025 | Mar 3, 2025 |
| S-8 | Employee stock plan registration | Jan 28, 2025 | — |
| EFFECT | Filing | Nov 27, 2024 | — |
| 424B3 | Prospectus | Nov 27, 2024 | — |
| CORRESP | Letter to the SEC | Nov 25, 2024 | — |
| UPLOAD | Letter from the SEC | Nov 25, 2024 | — |
| S-3 | Shelf registration | Nov 20, 2024 | — |
| 10-Q | Quarterly report | Nov 7, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 7, 2024 | Nov 7, 2024 |
| SC TO-I/A | Filing | Aug 14, 2024 | — |
| 10-Q | Quarterly report | Aug 8, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Agreement ended, Results of operations
|
Aug 8, 2024 | Aug 5, 2024 |
| SC TO-I | Filing | Jul 16, 2024 | — |
| 8-K |
Current report
Shareholder vote results
|
Jun 7, 2024 | Jun 6, 2024 |
| 10-Q | Quarterly report | May 9, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Results of operations
|
May 9, 2024 | May 9, 2024 |
| ARS | Annual report to shareholders | Apr 24, 2024 | Dec 31, 2023 |
| DEFA14A | Additional proxy material | Apr 24, 2024 | — |
| DEF 14A | Proxy statement | Apr 24, 2024 | Jun 6, 2024 |
| 10-K | Annual report | Feb 29, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Results of operations
|
Feb 29, 2024 | Feb 29, 2024 |
| S-8 | Employee stock plan registration | Jan 24, 2024 | — |
| 8-K |
Current report
Exit or restructuring costs, Regulation FD disclosure
|
Jan 18, 2024 | Jan 18, 2024 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Jan 5, 2024 | Jan 4, 2024 |
| 10-Q | Quarterly report | Nov 9, 2023 | Sep 30, 2023 |
| 8-K |
Current report
Results of operations
|
Nov 9, 2023 | Nov 9, 2023 |
| 8-K |
Current report
Other events
|
Oct 12, 2023 | Oct 12, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 11, 2023 | Oct 11, 2023 |
| 10-Q | Quarterly report | Aug 9, 2023 | Jun 30, 2023 |
| 8-K |
Current report
Results of operations
|
Aug 9, 2023 | Aug 9, 2023 |
| 8-K |
Current report
Shareholder vote results
|
Jun 9, 2023 | Jun 8, 2023 |
| 10-Q | Quarterly report | May 10, 2023 | Mar 31, 2023 |
| 8-K |
Current report
Results of operations
|
May 10, 2023 | May 10, 2023 |
| EFFECT | Filing | Apr 28, 2023 | — |
| ARS | Annual report to shareholders | Apr 28, 2023 | Dec 31, 2022 |
| DEFA14A | Additional proxy material | Apr 28, 2023 | — |
| 8-K |
Current report
Bylaw or fiscal year change
|
Apr 28, 2023 | Apr 24, 2023 |
| DEF 14A | Proxy statement | Apr 28, 2023 | Jun 8, 2023 |
| POS AM | Filing | Mar 1, 2023 | — |
| 10-K | Annual report | Mar 1, 2023 | Dec 31, 2022 |
| 8-K |
Current report
Results of operations
|
Mar 1, 2023 | Mar 1, 2023 |
| POSASR | Filing | Mar 1, 2023 | — |
| S-8 | Employee stock plan registration | Jan 25, 2023 | — |
| 10-Q | Quarterly report | Nov 8, 2022 | Sep 30, 2022 |
| 8-K |
Current report
Results of operations
|
Nov 8, 2022 | Nov 8, 2022 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Nov 4, 2022 | Nov 3, 2022 |
| 10-Q | Quarterly report | Aug 9, 2022 | Jun 30, 2022 |
| 8-K |
Current report
Results of operations
|
Aug 9, 2022 | Aug 9, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 8, 2022 | Jun 7, 2022 |
| 8-K |
Current report
Shareholder vote results
|
Jun 6, 2022 | Jun 2, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
May 26, 2022 | May 26, 2022 |
| 10-Q | Quarterly report | May 10, 2022 | Mar 31, 2022 |
| 8-K |
Current report
Results of operations
|
May 10, 2022 | May 10, 2022 |
| DEFA14A | Additional proxy material | Apr 22, 2022 | — |
| DEF 14A | Proxy statement | Apr 22, 2022 | Jun 2, 2022 |
| 10-K | Annual report | Mar 1, 2022 | Dec 31, 2021 |
| 8-K |
Current report
Results of operations
|
Mar 1, 2022 | Mar 1, 2022 |
| S-8 | Employee stock plan registration | Jan 24, 2022 | — |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Jan 6, 2022 | Jan 5, 2022 |
| 10-Q | Quarterly report | Nov 12, 2021 | Sep 30, 2021 |
| 8-K |
Current report
Results of operations
|
Nov 12, 2021 | Nov 12, 2021 |
| 8-K |
Current report
Material agreement
|
Oct 5, 2021 | Oct 4, 2021 |
| S-3ASR | Automatic shelf registration | Oct 4, 2021 | — |
| 10-Q | Quarterly report | Aug 13, 2021 | Jun 30, 2021 |
| 8-K |
Current report
Results of operations
|
Aug 13, 2021 | Aug 13, 2021 |
| 8-K |
Current report
Shareholder vote results
|
Jun 7, 2021 | Jun 2, 2021 |
| S-8 | Employee stock plan registration | May 21, 2021 | — |
| 10-Q | Quarterly report | May 14, 2021 | Mar 31, 2021 |
| 8-K |
Current report
Results of operations
|
May 14, 2021 | May 14, 2021 |
| DEFA14A | Additional proxy material | Apr 23, 2021 | — |
| DEF 14A | Proxy statement | Apr 23, 2021 | Jun 2, 2021 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Apr 6, 2021 | Apr 1, 2021 |
| 10-K | Annual report | Mar 3, 2021 | Dec 31, 2020 |
| 8-K |
Current report
Results of operations
|
Mar 3, 2021 | Mar 3, 2021 |
| 10-Q | Quarterly report | Nov 13, 2020 | Sep 30, 2020 |
| 8-K |
Current report
Results of operations
|
Nov 13, 2020 | Nov 13, 2020 |
| 8-K |
Current report
Bylaw or fiscal year change, Regulation FD disclosure
|
Sep 29, 2020 | Sep 29, 2020 |
| S-8 | Employee stock plan registration | Sep 28, 2020 | — |
| 424B4 | Prospectus | Sep 25, 2020 | — |
| EFFECT | Filing | Sep 24, 2020 | — |
| CERT | Filing | Sep 24, 2020 | — |
| S-1/A | Amended registration statement | Sep 24, 2020 | — |
| CORRESP | Letter to the SEC | Sep 22, 2020 | — |
| CORRESP | Letter to the SEC | Sep 22, 2020 | — |
| 8-A12B | Filing | Sep 21, 2020 | — |
| CORRESP | Letter to the SEC | Sep 21, 2020 | — |
| S-1/A | Amended registration statement | Sep 21, 2020 | — |
| UPLOAD | Letter from the SEC | Sep 17, 2020 | — |
| CORRESP | Letter to the SEC | Sep 11, 2020 | — |
| CORRESP | Letter to the SEC | Sep 4, 2020 | — |
| S-1 | Registration statement | Sep 4, 2020 | — |
| UPLOAD | Letter from the SEC | Aug 18, 2020 | — |
| DRS/A | Filing | Aug 3, 2020 | — |
| DRSLTR | Filing | Jul 31, 2020 | — |
| UPLOAD | Letter from the SEC | Jul 23, 2020 | — |
| DRS | Filing | Jun 26, 2020 | — |
| D | Filing | Mar 2, 2017 | — |
Showing 126 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- PMVP (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Princeton, NJ
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1699382
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.